How to re-position your point-of-care diagnostic for post-pandemic success
The most glaring theme at this year’s NextGenDx conference in Washington, DC, was that the diagnostic development industry must re-position itself in order to be successful in the post-pandemic era. We are firmly past the period of unprecedented boom in investment and development which was seen during the pandemic, where new diagnostic developers from across the full spectrum of diseases shifted the focus of their platforms towards COVID-19.
Now, with the demand for COVID-19 diagnostics rapidly diminishing and investment across the board returning to pre-pandemic levels, there has been some uncertainty around the future of these platforms. Many of the impressive technologies that were forged during the crisis are now looking for a new market vision to secure their future commercial success.
The event highlighted a number of key themes that will be important for diagnostic device developers to consider as they plan for success in the post-pandemic landscape.